| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.440.820 | 2.173.857 | 9.151.778 | 22.019.389 | 21.580.838 | 26.911.275 | 24.115.368 | 27.286.033 | 30.092.928 | 30.955.385 |
| Total Income - EUR | 1.448.535 | 2.222.139 | 10.215.877 | 22.132.084 | 21.713.294 | 27.079.696 | 24.177.724 | 27.375.698 | 30.187.796 | 31.020.909 |
| Total Expenses - EUR | 1.438.016 | 2.295.808 | 9.247.695 | 20.907.221 | 22.087.699 | 26.645.950 | 24.144.941 | 27.689.119 | 29.990.463 | 30.962.660 |
| Gross Profit/Loss - EUR | 10.518 | -73.669 | 968.182 | 1.224.863 | -374.404 | 433.746 | 32.783 | -313.421 | 197.333 | 58.249 |
| Net Profit/Loss - EUR | 7.416 | -73.669 | 810.266 | 1.056.098 | -405.532 | 364.489 | 20.387 | -313.421 | 183.019 | 29.862 |
| Employees | 3 | 3 | 7 | 32 | 68 | 66 | 63 | 66 | 61 | 57 |
Check the financial reports for the company - Pharma Vision Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.356 | 2.009.743 | 1.254.444 | 1.729.514 | 1.723.090 | 1.240.661 | 1.350.758 | 1.347.098 | 1.425.199 | 1.544.341 |
| Current Assets | 2.532.799 | 1.805.122 | 3.373.010 | 5.027.149 | 4.096.352 | 4.682.922 | 4.802.096 | 4.245.747 | 5.895.036 | 5.093.563 |
| Inventories | 400.679 | 95.404 | 1.097.070 | 1.886.311 | 1.355.922 | 1.671.956 | 2.523.795 | 1.611.378 | 2.686.749 | 2.202.713 |
| Receivables | 1.658.523 | 1.636.352 | 2.226.563 | 3.074.414 | 2.657.219 | 2.828.604 | 1.818.781 | 2.063.180 | 2.942.772 | 2.690.999 |
| Cash | 473.596 | 73.366 | 49.377 | 66.423 | 83.212 | 182.362 | 459.520 | 571.189 | 265.516 | 199.851 |
| Shareholders Funds | 1.848.783 | 1.756.348 | 2.479.373 | 3.207.218 | 2.340.256 | 2.333.955 | 2.270.665 | 1.444.739 | 1.546.466 | 1.502.125 |
| Social Capital | 90 | 178 | 263 | 258 | 253 | 248 | 243 | 243 | 243 | 241 |
| Debts | 700.371 | 2.058.517 | 2.148.926 | 3.564.154 | 3.475.145 | 3.580.503 | 3.862.156 | 4.127.695 | 5.745.888 | 5.098.542 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.629 | 10.119 | 7.110 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Pharma Vision Plus Srl